Wave Life Sciences Ltd. (WVE) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Wave Life Sciences Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.898 Good morning and welcome to the Way of Life Sciences fourth quarter and full year 2025 00:00:04.898 -- 00:00:09.985 earnings conference call. At this time, all participants are in a listen-only 00:00:09.985 -- 00:00:14.631 mode. As a reminder, this call is being recorded and webcast. 00:00:14.631 -- 00:00:18.937 I'll now turn the call over to Kate Roush, Vice President of Corporate Affairs and Investor 00:00:18.937 -- 00:00:21.381 Relations. Please go ahead. 00:00:21.381 -- 00:00:24.145 Thank you, Sophie. And good morning to everyone on the call. 00:00:24.145 -- 00:00:27.610 Earlier this morning, we issued a press release outlining our fourth quarter and full 00:00:27.610 -- 00:00:31.851 year 2025 earnings updates. Joining me today with prepared remarks are Dr. 00:00:31.851 -- 00:00:34.855 Paul Bono, President and Chief Executive Officer, Dr. 00:00:34.855 -- 00:00:38.860 Chris Wright, Chief Medical Officer, and Kyle Moran, Chief Financial Officer. 00:00:38.860 -- 00:00:43.306 Dr. Eric Engelson, Chief Scientific Officer, will be available for questions after the 00:00:43.306 -- 00:00:47.290 call. The press release issued this morning is available on the investor section of our 00:00:47.290 -- 00:00:49.891 website, www.wavelifesciences.com. 00:00:50.403 -- 00:00:53.807 Before we begin, I would like to remind you that discussions during this conference call 00:00:53.807 -- 00:00:57.051 will include forward-looking statements. These statements are subject to several risks 00:00:57.051 -- 00:01:00.616 and uncertainties that could cause our actual results to differ materially from those 00:01:00.616 -- 00:01:02.778 described in these forward-looking statements. 00:01:02.778 -- 00:01:06.343 The factors that could cause actual results to d...